NO20021205L - Faste lipid formuleringer - Google Patents

Faste lipid formuleringer

Info

Publication number: NO20021205L
Authority: NO; Norway
Prior art keywords: solid lipid; lipid formulations; formulations; solid; lipid
Prior art date: 1999-09-13

Application number

NO20021205A

Other languages

English (en)

Other versions

NO20021205D0 (no

NO328889B1 (no

Inventor

Passchier Christiaan De Smidt

Paul Hadvary

Hans Lengsfeld

Marcel Schmid

David Macfarland Small

Hans Steffen

Joseph Tardio

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-13

Filing date

2002-03-12

Publication date

2002-03-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021205(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-03-12 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2002-03-12 Publication of NO20021205L publication Critical patent/NO20021205L/no

2002-03-12 Publication of NO20021205D0 publication Critical patent/NO20021205D0/no

2010-06-07 Publication of NO328889B1 publication Critical patent/NO328889B1/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Obesity (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)

NO20021205A 1999-09-13 2002-03-12 Faste lipid-formuleringer, fremstilling av slike samt anvendelse av slike for fremstilling av medikament for forebygging og behandling av fedme. NO328889B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP99118179		1999-09-13
PCT/EP2000/008857 WO2001019378A2 (en)	1999-09-13	2000-09-11	Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols

Publications (3)

Publication Number	Publication Date
NO20021205L true NO20021205L (no)	2002-03-12
NO20021205D0 NO20021205D0 (no)	2002-03-12
NO328889B1 NO328889B1 (no)	2010-06-07

Family

ID=8238989

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021205A NO328889B1 (no)	1999-09-13	2002-03-12	Faste lipid-formuleringer, fremstilling av slike samt anvendelse av slike for fremstilling av medikament for forebygging og behandling av fedme.

Country Status (36)

Country	Link
US (1)	US6703369B1 (no)
EP (1)	EP1216048B1 (no)
JP (1)	JP4217017B2 (no)
KR (1)	KR100523879B1 (no)
CN (1)	CN1197554C (no)
AR (1)	AR025609A1 (no)
AT (1)	ATE285783T1 (no)
AU (1)	AU769016B2 (no)
BR (1)	BRPI0013940B1 (no)
CA (1)	CA2383036C (no)
CO (1)	CO5210857A1 (no)
CZ (1)	CZ301844B6 (no)
DE (1)	DE60017156T2 (no)
EG (1)	EG24225A (no)
ES (1)	ES2233444T3 (no)
GC (1)	GC0000259A (no)
HK (1)	HK1049798B (no)
HR (1)	HRP20020206B1 (no)
HU (1)	HU229037B1 (no)
IL (2)	IL148570A0 (no)
JO (1)	JO2300B1 (no)
MA (1)	MA26817A1 (no)
ME (1)	ME00675B (no)
MX (1)	MXPA02002662A (no)
MY (1)	MY127430A (no)
NO (1)	NO328889B1 (no)
NZ (1)	NZ517396A (no)
PE (1)	PE20010661A1 (no)
PL (1)	PL199869B1 (no)
PT (1)	PT1216048E (no)
RS (1)	RS50373B (no)
RU (1)	RU2248218C2 (no)
SI (1)	SI1216048T1 (no)
TR (1)	TR200200605T2 (no)
WO (1)	WO2001019378A2 (no)
ZA (1)	ZA200201249B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas
RU2241462C2 (ru) *	2000-07-28	2004-12-10	Ф. Хоффманн-Ля Рош Аг	Новая фармацевтическая композиция
US20030027786A1 (en) *	2001-06-06	2003-02-06	Karsten Maeder	Lipase inhibiting composition
US6730319B2 (en) *	2001-06-06	2004-05-04	Hoffmann-La Roche Inc.	Pharmaceutical compositions having depressed melting points
DE10251963A1 (de) *	2002-11-08	2004-05-19	Lts Lohmann Therapie-Systeme Ag	Transmucosale pharmazeutische Darreichungsform
US8372430B2 (en) *	2002-12-17	2013-02-12	The Procter & Gamble Company	Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
BR0318167A (pt) *	2003-03-04	2006-02-21	Nostrum Pharmaceuticals Inc	formulação de liberação controlada contendo um material hidrofóbico como o agente de liberação controlada
FI20045076L (fi) *	2004-03-15	2005-09-16	Bioferme Oy	Funktionaalinen elintarvike
AU2005297923B2 (en) *	2004-10-25	2010-12-23	Japan Tobacco Inc.	Solid medicinal preparation improved in solubility and stability and process for producing the same
KR100669497B1 (ko) *	2005-08-17	2007-01-16	보람제약주식회사	안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
US20070148245A1 (en) *	2005-12-22	2007-06-28	Ilan Zalit	Compressed solid dosage forms with drugs of low solubility and process for making the same
CA2626234A1 (en) *	2005-12-22	2007-06-28	Teva Pharmaceutical Industries Ltd.	Compressed solid dosage forms with drugs of low solubility and process for making the same
EP1808163A1 (en) *	2005-12-22	2007-07-18	Teva Pharmaceutical Industries Ltd.	Compressed solid dosage forms with drugs of low solubility and process for making the same
KR101252635B1 (ko)	2006-04-20	2013-04-10	(주)아모레퍼시픽	리파아제 저해제 및 친유성 오일흡수제를 포함하는 약학조성물 및 이로부터 제조된 경구 투여용 제제
KR100903504B1 (ko) *	2007-05-18	2009-06-17	강태용	비라칸사스 열매 추출물질을 포함하는 기능식품 및 체중 감소제
EP2076248A2 (en) *	2007-08-17	2009-07-08	Teva Pharmaceutical Industries Ltd.	Methods and compositions for controlling the bioavailability of poorly soluble drugs
EP2036575B1 (en) *	2007-09-12	2010-08-18	Mader S.r.l.	Pharmaceutical compositions for oral use for treating patients affected by obesity
PL216542B1 (pl)	2008-03-20	2014-04-30	Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna	Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
US8309107B2 (en)	2008-10-06	2012-11-13	Banner Pharmacaps, Inc.	Stable solutions of orlistat for pharmaceutical dosage forms
BRPI0901602B8 (pt)	2009-04-03	2021-05-25	Ems S/A	formulação farmacêuticas
UA107369C2 (en)	2010-02-01	2014-12-25	Lab Bago S A	Pharmaceutical composition with anti-obesity activity comprising a premixture of pure orlistat and preparation process
EP2486805A1 (en) *	2011-02-11	2012-08-15	Puratos N.V.	An emulsion whippable at room-temperature
RU2532044C1 (ru) *	2011-04-14	2014-10-27	Й-Оил Миллс, Инц.	Фракционированное масло или жир на основе пальмового масла, композиция масла или жира и пищевые продукты, содержащие эту композицию
CN102552168B (zh) *	2012-01-31	2013-08-07	杭州华东医药集团生物工程研究所有限公司	一种含有奥利司他的药物组合物及其制备方法
GB2501535A (en)	2012-04-26	2013-10-30	Sony Corp	Chrominance Processing in High Efficiency Video Codecs
SG10201704858PA (en) *	2012-05-31	2017-07-28	Repros Therapeutics Inc	Formulations and methods for vaginal delivery of antiprogestins
CA2923838A1 (en) *	2013-10-28	2015-05-07	Nestec S.A.	Monoacylglycerols for use in conjunction with a lipase inhibitor and/or diets low in fat and/or calories
CN115105476B (zh) *	2021-03-23	2023-11-14	山东新时代药业有限公司	一种奥利司他冻干口服制剂及其制备工艺

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1247547A (en) *	1983-06-22	1988-12-28	Paul Hadvary	Leucine derivatives
FR2710264B1 (fr) *	1993-09-21	1995-12-08	Rocher Yves Biolog Vegetale	Utilisation pour le traitement des peaux mixtes d'une quantité efficace de substances actives.
AU5185398A (en) *	1996-12-04	1998-06-29	James S Pincott	Process and apparatus for making crumb rubber from scrap tyres
ES2239799T3 (es)	1997-02-05	2005-10-01	F. Hoffmann-La Roche Ag	Uso de tetrahidrolipstatina en el tratamiento de la diabetes tipo ii.
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US6267952B1 (en)	1998-01-09	2001-07-31	Geltex Pharmaceuticals, Inc.	Lipase inhibiting polymers
TR200100471T2 (tr)	1998-08-14	2001-07-23	F.Hoffmann-La Roche Ag	Lipaz inhibitörleri içeren farmasötik bileşimler
AU759388B2 (en) *	1998-08-14	2003-04-10	Cheplapharm Arzneimittel Gmbh	Pharmaceutical compositions containing lipase inhibitors and chitosan
AR025609A1 (es) *	1999-09-13	2002-12-04	Hoffmann La Roche	Formulaciones lipidas solidas

2000
- 2000-09-08 AR ARP000104722A patent/AR025609A1/es active IP Right Grant
- 2000-09-11 IL IL14857000A patent/IL148570A0/xx active IP Right Grant
- 2000-09-11 TR TR2002/00605T patent/TR200200605T2/xx unknown
- 2000-09-11 CZ CZ20021277A patent/CZ301844B6/cs not_active IP Right Cessation
- 2000-09-11 PT PT00964158T patent/PT1216048E/pt unknown
- 2000-09-11 KR KR10-2002-7003247A patent/KR100523879B1/ko not_active Expired - Lifetime
- 2000-09-11 BR BRPI0013940A patent/BRPI0013940B1/pt not_active IP Right Cessation
- 2000-09-11 PL PL356154A patent/PL199869B1/pl unknown
- 2000-09-11 EP EP00964158A patent/EP1216048B1/en not_active Expired - Lifetime
- 2000-09-11 AT AT00964158T patent/ATE285783T1/de active
- 2000-09-11 RU RU2002107450/15A patent/RU2248218C2/ru active
- 2000-09-11 NZ NZ517396A patent/NZ517396A/en not_active IP Right Cessation
- 2000-09-11 JP JP2001523010A patent/JP4217017B2/ja not_active Expired - Lifetime
- 2000-09-11 CA CA002383036A patent/CA2383036C/en not_active Expired - Lifetime
- 2000-09-11 WO PCT/EP2000/008857 patent/WO2001019378A2/en not_active Ceased
- 2000-09-11 HK HK03101988.9A patent/HK1049798B/zh not_active IP Right Cessation
- 2000-09-11 DE DE60017156T patent/DE60017156T2/de not_active Expired - Lifetime
- 2000-09-11 HU HU0202762A patent/HU229037B1/hu unknown
- 2000-09-11 AU AU75177/00A patent/AU769016B2/en not_active Expired
- 2000-09-11 JO JO2000156A patent/JO2300B1/en active
- 2000-09-11 MX MXPA02002662A patent/MXPA02002662A/es active IP Right Grant
- 2000-09-11 RS YUP-136/02A patent/RS50373B/sr unknown
- 2000-09-11 SI SI200030589T patent/SI1216048T1/xx unknown
- 2000-09-11 MY MYPI20004207 patent/MY127430A/en unknown
- 2000-09-11 ES ES00964158T patent/ES2233444T3/es not_active Expired - Lifetime
- 2000-09-11 ME MEP-2008-909A patent/ME00675B/me unknown
- 2000-09-11 CN CNB008126798A patent/CN1197554C/zh not_active Expired - Lifetime
- 2000-09-11 HR HR20020206A patent/HRP20020206B1/xx not_active IP Right Cessation
- 2000-09-12 CO CO00068855A patent/CO5210857A1/es active IP Right Grant
- 2000-09-12 EG EG20001160A patent/EG24225A/xx active
- 2000-09-13 PE PE2000000950A patent/PE20010661A1/es not_active IP Right Cessation
- 2000-09-13 GC GCP2000906 patent/GC0000259A/en active
- 2000-09-13 US US09/660,700 patent/US6703369B1/en not_active Expired - Lifetime
2002
- 2002-02-13 ZA ZA200201249A patent/ZA200201249B/en unknown
- 2002-03-07 IL IL148570A patent/IL148570A/en unknown
- 2002-03-11 MA MA26544A patent/MA26817A1/fr unknown
- 2002-03-12 NO NO20021205A patent/NO328889B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK1049798B (zh)	2005-08-05
MA26817A1 (fr)	2004-12-20
KR20020060177A (ko)	2002-07-16
HUP0202762A3 (en)	2005-04-28
MEP90908A (en)	2011-12-20
HRP20020206B1 (en)	2011-02-28
BR0013940A (pt)	2002-05-14
RU2002107450A (ru)	2004-01-10
US6703369B1 (en)	2004-03-09
AR025609A1 (es)	2002-12-04
CO5210857A1 (es)	2002-10-30
WO2001019378A3 (en)	2001-05-10
RS50373B (sr)	2009-11-10
PL199869B1 (pl)	2008-11-28
CN1197554C (zh)	2005-04-20
DE60017156D1 (de)	2005-02-03
YU13602A (sh)	2006-01-16
IL148570A (en)	2007-03-08
CN1373659A (zh)	2002-10-09
NO20021205D0 (no)	2002-03-12
HRP20020206A2 (en)	2004-04-30
DE60017156T2 (de)	2006-01-05
NO328889B1 (no)	2010-06-07
RU2248218C2 (ru)	2005-03-20
HK1049798A1 (en)	2003-05-30
JP4217017B2 (ja)	2009-01-28
SI1216048T1 (en)	2005-06-30
AU769016B2 (en)	2004-01-15
ATE285783T1 (de)	2005-01-15
NZ517396A (en)	2003-10-31
JP2003509373A (ja)	2003-03-11
ES2233444T3 (es)	2005-06-16
HU229037B1 (en)	2013-07-29
EP1216048B1 (en)	2004-12-29
HUP0202762A2 (hu)	2003-01-28
MY127430A (en)	2006-11-30
JO2300B1 (en)	2005-09-12
ME00675B (me)	2011-12-20
CZ301844B6 (cs)	2010-07-07
EG24225A (en)	2008-11-10
TR200200605T2 (tr)	2002-08-21
EP1216048A2 (en)	2002-06-26
WO2001019378A2 (en)	2001-03-22
BRPI0013940B1 (pt)	2016-06-21
ZA200201249B (en)	2003-07-30
KR100523879B1 (ko)	2005-10-26
IL148570A0 (en)	2002-09-12
CA2383036C (en)	2006-01-10
PL356154A1 (en)	2004-06-14
PE20010661A1 (es)	2001-06-25
MXPA02002662A (es)	2002-07-30
PT1216048E (pt)	2005-04-29
GC0000259A (en)	2006-11-01
CZ20021277A3 (cs)	2003-04-16
CA2383036A1 (en)	2001-03-22
AU7517700A (en)	2001-04-17

Publication	Publication Date	Title
NO20021205L (no)	2002-03-12	Faste lipid formuleringer
ID23299A (id)	2000-04-05	Formulasi-formulasi farmasi
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
ID23546A (id)	2000-05-04	Formulasi-formulasi ziprasidon
NO20004240L (no)	2000-10-18	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
IS6040A (is)	2001-08-07	Valdekoxib efnablöndur
DE60105178D1 (de)	2004-09-30	Pestizide formulierungen
MA24473A1 (fr)	1998-10-01	Formulations
DE60005321D1 (de)	2003-10-23	Agrochemische formulierungen
ID29635A (id)	2001-09-06	Formulasi mikrokapsul
PT1237408E (pt)	2004-06-30	Formulacoes para derramar
EE200200150A (et)	2003-04-15	Preparaat
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
IS6398A (is)	2002-05-27	Lyfjablöndur
NO20002126L (no)	2000-05-04	Formulering med forlenget frigjøring
NO20020151D0 (no)	2002-01-11	Veksthormonformuleringer
ATE267190T1 (de)	2004-06-15	Vitamin d - analoga
ID27655A (id)	2001-04-19	Formulasi mikrokapsul
ID30032A (id)	2001-11-01	Formulasi farmasi
ATE268116T1 (de)	2004-06-15	Mesotrion-formulierungen
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica

Legal Events

Date	Code	Title	Description
2020-04-27	MM1K	Lapsed by not paying the annual fees